Synthetic Biologics (SYN) Reports 2016 EPS of ($0.29)

Synthetic Biologics (NYSE: SYN) reported 2016 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)